» Authors » Jung Ho Yu

Jung Ho Yu

Explore the profile of Jung Ho Yu including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 29
Citations 686
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Khan S, Zhong X, Das N, Yu J, Natarajan A, Anders D, et al.
Eur J Nucl Med Mol Imaging . 2024 Dec; PMID: 39729092
Purpose: Nanoparticles are highly efficient vectors for ferrying contrast agents across cell membranes, enabling ultra-sensitive in vivo tracking of single cells with positron emission tomography (PET). However, this approach must...
2.
Yu J, Jeong M, Cruz E, Alam I, Tumbale S, Zlitni A, et al.
ACS Nano . 2023 Jan; 17(3):2554-2567. PMID: 36688431
Raman spectroscopy provides excellent specificity for preclinical imaging through a readout of fingerprint-like spectra. To achieve sufficient sensitivity for Raman imaging, metallic gold nanoparticles larger than 10 nm were employed...
3.
Yu J, Steinberg I, Davis R, Malkovskiy A, Zlitni A, Radzyminski R, et al.
ACS Nano . 2021 Nov; 15(12):19956-19969. PMID: 34797988
multiplexed imaging aims for noninvasive monitoring of tumors with multiple channels without excision of the tissue. While most of the preclinical imaging has provided a number of multiplexing channels up...
4.
Olson J, Yu J, Thimes R, Camden J
J Biophotonics . 2021 Oct; 15(1):e202100158. PMID: 34609064
Multiphoton microscopy using short-wave infrared (SWIR) radiation offers nondestructive and high-resolution imaging through tissue. Two-photon fluorescence (TPF), for example, is commonly employed to increase the penetration depth and spatial resolution...
5.
Jung K, Kim T, Yu J, Rhee S, Zhao W, Ha B, et al.
Nat Biomed Eng . 2020 Jun; 4(8):835-844. PMID: 32541917
In vivo molecular imaging can measure the average kinetics and movement routes of injected cells through the body. However, owing to non-specific accumulation of the contrast agent and its efflux...
6.
Park S, Won D, Lee B, Escobedo D, Esteva A, Aalipour A, et al.
Nat Biomed Eng . 2020 May; 4(6):662. PMID: 32382068
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
7.
Park S, Won D, Lee B, Escobedo D, Esteva A, Aalipour A, et al.
Nat Biomed Eng . 2020 Apr; 4(6):624-635. PMID: 32251391
Technologies for the longitudinal monitoring of a person's health are poorly integrated with clinical workflows, and have rarely produced actionable biometric data for healthcare providers. Here, we describe easily deployable...
8.
Yu J, Kim J, Hyeon T, Yang J
J Chem Phys . 2020 Jan; 151(24):244701. PMID: 31893917
Doping is one of the key technologies in modern semiconductor science and industry. However, the synthetic control of doped nanocrystals is difficult to achieve. Here, we report the facile synthesis...
9.
Jung K, Jo H, Yu J, Gambhir S, Pratx G
Biomaterials . 2018 Jun; 177:139-148. PMID: 29890363
Treating the hypoxic region of the tumor remains a significant challenge. The goals of this study are to develop an exosome platform that can target regions of tumor hypoxia and...
10.
Park S, Aalipour A, Vermesh O, Yu J, Gambhir S
Nat Rev Mater . 2018 Jun; 2(5). PMID: 29876137
Nanodiagnostics as a field makes use of fundamental advances in nanobiotechnology to diagnose, characterize and manage disease at the molecular scale. As these strategies move closer to routine clinical use,...